Increased Earnings Estimates Seen for Nevro (NVRO): Can It Move Higher? – Tale of the Tape

Zacks

Nevro Corp. (NVRO) is a medical device company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.

These positive earnings estimate revisions suggest that analysts are becoming more optimistic on NVRO’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Nevro could be a solid choice for investors.

Current Quarter Estimates for NVRO

In the past 30 days, 3 estimates have gone higher for Nevro while none have gone lower in the same time period. The trend has been pretty favorable too, with estimates narrowing from a loss of 63 cents a share 30 days ago, to a loss of 51 cents today, a move of 19%.

Current Year Estimates for NVRO

Meanwhile, Nevro’s current year figures are also looking quite promising, with 3 estimates moving higher in the past month, compared to 0 lower. The consensus estimate trend has also seen a boost for this time frame, narrowing from $2.26 per share 30 days ago to $1.89 per share today, an increase of 16.4%.

Bottom Line

The stock has also started to move higher lately, adding 13.7% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #3 (Hold) stock to profit in the near future.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply